Skip to content

Author

S. H. Assaad-Khalil

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Empagliflozin’s role in cardiometabolic disease treatment: an Egyptian expert’s view

EMPA extends beyond glucose-lowering by reducing cardiorenal morbidity and mortality in patients with or without diabetes, supporting its suitability for the large Muslim population.

S. H. Assaad-Khalil, Fawzy Elmessallamy, K. E. Elhadidy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.